Advances in machine learning for cardiac event prediction: where can we still improve? [0.03%]
机器学习在心脏病事件预测中的进展：我们还可以改进什么？
Sasha-Ann East,Kameswari Maganti,Partho Sengupta
Sasha-Ann East
Introduction: Artificial intelligence (AI) is playing a transformative role in cardiovascular care by enabling more precise prediction of adverse clinical events across prevention, imaging, electrophysiology, and interven...
Moving towards digital twins for precision cardiac electrophysiology: overcoming technical and clinical challenges [0.03%]
迈向数字孪生：精准心脏电生理技术与临床挑战不容小觑
Melania Buonocunto,Alexander Jung,Stefan Meier et al.
Melania Buonocunto et al.
Introduction: Precision cardiac electrophysiology seeks to provide healthcare strategies tailored to the individual patient. The concept of digital twins is fundamental to this approach. Digital twins in cardiac electroph...
Getting ahead of sudden cardiac arrest in pediatric hypertrophic cardiomyopathy [0.03%]
儿童肥厚型心肌病中抢先应对突发心脏骤停
Shuenn-Nan Chiu,Wei-Chieh Tseng,Jyh-Ming Jimmy Juang et al.
Shuenn-Nan Chiu et al.
Introduction: Sudden cardiac arrest (SCA) remains one of the most devastating complications of pediatric hypertrophic cardiomyopathy (HCM). Despite major advances in genetic diagnostics, cardiac imaging, and risk stratifi...
Claudio Tana,Nicol Bernardinello,Paolo Spagnolo et al.
Claudio Tana et al.
Efficacy and safety of CSL112 (apolipoprotein A-I) on modulation of HDL-Related biomarkers and reverse cholesterol transport in atherosclerosis and myocardial infarction: a systematic review and meta-analysis [0.03%]
CSL112（载脂蛋白A-I）对动脉粥样硬化和心肌梗死中HDL相关生物标志物和胆固醇逆向转运调节的有效性和安全性：系统评价和meta分析
Asma Fatima,Umais Ahmed Shaikh,Syed Hassan Ali et al.
Asma Fatima et al.
Background: Despite statin therapy, cardiovascular disease remains a leading cause of mortality. CSL112 enhances HDL function and reverse cholesterol transport, offering a novel strategy for atherosclerotic cardiovascular...
Time for a new category: "acute-on-chronic" hypertensive target organ damage [0.03%]
急性慢性高血压靶器官损害的新类别分类迫在眉睫
Goran Koraćević,Milovan Stojanovic,Dragan Simic et al.
Goran Koraćević et al.
Introduction: The aims of this paper are as follows: 1) To analyze the evolution of understanding of hypertensive target organ damages (TODs); 2) To see if the concept of 'acute-on-chronic TOD' is commented so far and to ...
Management patterns of acute coronary syndrome among patients with malignancy: a systematic review and meta-analysis [0.03%]
恶性肿瘤患者急性冠脉综合征的管理规律：系统评价和Meta分析
Muhammad Ahmad Nadeem,Abdullah Ahmad,Abdul Rafeh Awan et al.
Muhammad Ahmad Nadeem et al.
Introduction: Patients presenting with acute coronary syndrome (ACS) and a history of cancer are high-risk. Prior studies suggest differences in acute treatment and discharge prescribing compared with non-cancer patients....
Clinical identification of familial chylomicronemia syndrome and novel therapeutic options [0.03%]
家族性高乳糜微粒血症候群的临床识别及新型治疗选择
Shyann Hang,Robert A Hegele
Shyann Hang
Introduction: Hypertriglyceridemia (HTG) is a heterogeneous metabolic disorder driven by both genetic susceptibility and secondary factors. Most cases of severe HTG (triglyceride [TG] >10 mmol/L [>885 mg/dL]) have multifa...
Biodegradable devices for transcatheter patent foramen ovale closure: current evidence and future directions [0.03%]
可降解材料经导管卵圆孔未闭封堵器械的现状及未来展望
Allahdad Khan,Mishaim Khan,Harshith Thyagaturu et al.
Allahdad Khan et al.
Introduction: Biodegradable devices for transcatheter patent foramen ovale (PFO) closure offer an alternative to nitinol occluders by enabling effective closure without leaving a permanent implant. Metallic devices have e...
Sex-related differences in the prognosis of asymptomatic mitral regurgitation: an analysis of nationwide claims data [0.03%]
无症状二尖瓣反流预后的性别差异——全国索赔数据分析结果
Laura Acar,Christian-Alexander Behrendt,Ursula Marschall et al.
Laura Acar et al.
Background: Asymptomatic mitral regurgitation (MR) can lead to long-term morbidity and mortality. While sex differences are well established in cardiovascular disease, data for asymptomatic MR are limited. Systemic factor...